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ABSTRACT
Orthostatic intolerance, following space flight, has received substantial attention
because of the possibility that it compromises astronaut safety and reduces the ability of
astronauts to function at peak performance levels upon return to a lg environment. Many
pre- and post-flight studies are performed to evaluate changes in hemodynamic responses
to orthostatic challenges after Shuttle missions. The purpose of this present project was
to validate bioimpedance as a means to acquire stroke volume and other hemodynamic
information in these studies.
In this study, ten male and 10 female subjects were subjected to simultaneous
measurements of thoracic bioimpedance and Doppler ultrasonic velocimetry under supine,
10o head down and 30o head up conditions. Paired measurements were made during 6
periods of 5 seconds ofbreath holding, over a 2 minute period, for each of the three
positions.
Stroke volume was calculated by three bioimpedance techniques and ultrasonic
Doppler. The three bioimpedance methods included calculation of stroke volume:
1. using Kubicek's basic equation and obtaining peak dz/dt by numerical
differentiation of the delta-z waveforms ex post facto. Resistivity values, taken
from the literature, were 135fl-cm for all cases.
2. using Sramek's modifications of Kubicek's equation and obtaining dz/dt by
numerical differentiation of the delta-z waveforms ex post facto.
3. from the digital output of the BoMed ® NCCOM3 Cardiovascular Monitor in
which peak dz/dt is determined by electrical differentiation and an internal, noise-
eliminating algorithm.
Regression analysis showed no discernible relationship between any of the three
bioimpedance techniques and Doppler ultrasound. R 2 values were <0.1 in all cases.
Percent change in stroke index from the supine to head up or head down position showed
all four methods demonstrated significant differences as a function of tilt with no
significant differences between the 4 methods (P<0.05). However, additional analysis
demonstrated that the major changes in stroke volume measurements were due, in part, to
thoracic fluid shifts and subsequent changes in Thoracic Fluid Index (Basal Impedance).
The results of this study demonstrate a poor correlation between Doppler
ultrasound and electrical bioimpedance measurements of stroke volume. The study also
indicated that apparent changes in stroke volume were due, in part, to changes in basal
impedance and not due to changes in dz/dt or ventricular ejection time. At this time,
bioimpedance measurements, using the methods described in this paper, are not
recommended for quantitative determinations of stroke volume and cardiac output in the
US space program. Measurements of relative changes in stroke volume and cardiac
output may be possible on the same subject however further analysis of the data will be
required to determine statistical significance.
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INTRODUCTION
The phenomenon of orthostatic hypotension is manifested as pre syncope or
syncope that occurs in some individuals undergoing postural changes from a supine (or
seated) to an upright position. The effect is caused by the sudden movement of blood
from the upper body to the lower extremities during standing. This causes a reduction in
the amount of blood flowing to the heart (reduced end-diastolic volume) which responds
by reducing the force of contraction (Frank-Starling Law). This effect is normally short-
lived because baroreceptors sense a reduction in blood pressure and respond, within a few
seconds, by sending commands to correct the deficit. The normal response mechanism is
complex but includes an increased heart rate, increased force of contraction and peripheral
vasoconstriction. If these mechanisms fail, the net result is a reduction in oxygenated
blood to the brain and subsequent syncope. Figure 1 shows an episode oforthostatic
hypotension that occurred during a "Stand Test" in the cardiovascular laboratory. The
test results were more pronounced, in this case, because of voluntary fluid depletion on
the part of the subject.
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Figure 1.-An episode oforthostatic hypotension that occurred during a Stand Test. The
substantial decrease in arterial pressure was corrected when the subject resumed a supine
position.
In the space program this same phenomenon has been reported in a substantial
number of astronauts after space flight. Microgravity exposure produces a redistribution
of blood from the lower extremities. The body responds to this anomalous fluid challenge
by eliminating apparent excess fluid while in microgravity. When the individual returns to
the lg environment, in a fluid-depleted-state, he is more susceptible to orthostatic
hypotension. This orthostatic intolerance can cause key personnel to function below peak
performance levels. Potential problems of this type are of concern and attempts are being
made to eliminate the hazard.
Cardiac output is one of the most important physiologic variables to be monitored
in the study orthostatic intolerance. At present non invasive cardiac output is measured, in
the Cardiovascular Laboratory at JSC, using B-Mode and continuous wave Doppler
ultrasonic velocimetry. The process requires measurement of the aortic outflow tract
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diameter just distal to the aortic valve using pulsed echo (B-Mode) ultrasound. Beat=by-
beat continuous wave (CW) Doppler measurements of aortic outflow blood velocity are
then made at the suprasternal notch. Stroke volume is computed by integrating over time,
the area under the ejection velocity curve to obtain mean ejection velocity for one cardiac
cycle. The mean velocity times the aortic cross sectional area times the ventricular
ejection time gives stroke volume. Stroke volume times heart rate gives cardiac
output. The process of determining cardiac output using ultrasound requires
sophisticated, expensive equipment and highly skilled technical support. Other non
invasive methods of cardiac output measurement such as radio nuclide imaging using
gated blood pool scans, magnetic resonance imaging and procedures using inhaled gases
are not appropriate for use in the space Shuttle or pre- and post- landing phases of Shuttle
flight.
We proposed that the measurement of stroke volume and cardiac output could be
simplified through the use of electrical bioimpedance measurements. Bioimpedance
cardiac monitors are less expensive, easier to apply to the test subject, require less training
for proper use and are less bulky than Doppler ultrasound. Impedance cardiology, first
described by Kubicek (1966) has the potential of being a major contributor to the field of
non invasive cardiology except that the source of the cardiac bioimpedance signal, despite
numerous attempts, has never been adequately identified. In a 1988 note on "Continuous
Cardiac Output Monitoring by Electrical Bioimpedance" the American College of
Cardiology concludes "Due to limitations in accuracy in certain subgroups, the use of
empirical formulas, and a relative lack of correlation with other presently used non-
invasive methods, the technique is considered investigational." Although numerous
investigators (Geddes, et al. 1966, Judy, et al., 1969, Baker, et al., 1971, Pate, et al.,
1975) have evaluated the efficacy of cardiac output by bioimpedance the space program
has not accepted bioimpedance as a viable means to acquire cardiac output information.
It was the purpose of this present study to attempt to validate cardiac
bioimpedance measurements using the BoMed ® NCCOM3 Cardiovascular Monitor
already in-house at the Johnson Space Center to compare against simultaneously-acquired
ultrasonic Doppler measurements of stroke volume. Since the analog output of the
NCCOM3 included AZ it was also possible to determine stroke volume using the Kubicek,
et al. classic equation and the modified equation proposed by Sramek (1982) and
Bemstein (1986).
Development of the Bioimpeclance Equations used in this Study
Impedance plethysmography studies(Nyboer, 1970) have demonstrated that, for a volume
conductor, a change in volume, AV, is related to a changes in electrical impedance, AZ, by
the following equation
where
AV =-_TAZ (I)
Zo
p is the electrical resistivity of blood at the excitation frequency used;
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L is the distance between voltage sensing electrodes;
Zo is the mean basal impedance between voltage sensing electrodes.
If AZ is taken as the extrapolated maximum impedance change during
systole(Ventricular Ejection Time) then AV represents the volume change during systole
or stroke volume(SV). Kubicek determined that the peak value of the first time derivative
of the AZ waveform, dz/dt, could be used instead of the extrapolated value. Figure 2
demonstrates this concept.
Figure 2.-An example ofECG, AZ, dz/dt and CW Doppler ultrasound signals taken
simultaneously from the same subject. The diagram clearly demonstrates that the positive
dz/dt corresponds to the ejection phase and that the peak negative dz/dt indicates the end
of systole. The difference, in seconds, between these two events is the Ventricular
Ejection Time (VET).
Kubicek's modification of equation (1) for stroke volume(SV K) then becomes
rErpL
dr J_,,. (2)
st,,= Zo
where peak dgdt and VET are taken from the analog signal as described in Figure 2.
Quail, et al. (1981) rearranged the Kubicek equation to solve for p such that
Sg .
Ldt J ._
(3)
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Using dogs as test subjects, by varying hematocrits and other physiological parameters and
using an electromagnetic flowrneter to measure stroke volume, Quail and his associates
determined that p was essentially constant at 135f2-cm. Given this observation, Bernstein
0986) rearranged the Kubicek equation (2) to eliminate p. Since
_ pL 2
Z - _ solving for p such that p =
modified Kubicek equation becomes
and substituting in equation (2) the
SV = _'_
Zo (4)
Sramek determined that the nr2L represented a "Volume of Electrically
Participating Tissue" (VEPT) a truncated cone whose volume was determined,
experimentally, to be 1/3 that of a cylinder of the same radius and that the distance, L,
between voltage sensing electrodes was 0.17*Height. Bernstein provided a nomogram to
assist in the calculation of VEPT from the subject's height and weight which took into
account the differences between male and female subjects. The Sramek (SVs) equation,
modified from (4) above was
SVs=
Zo (S)
Equation (5) is the same equation used by the BoMed NCCOM3 Cardiac Monitor,
SVBM. The difference between SV S and SVBM lies in the method that the peak dz/dt is
obtained. This is explained further in the Methods section.
MATERIALS AND METHODS
Ten normal female and 10 normal male volunteers, who had current NASA Class
III physical examinations, were selected for this study. The subjects read and signed the
NASA Human Research Minimal Risk Informed Consent Form prior to testing. Each
subject drank 0.5 Liters of water just prior to the test in order to assure a reasonable level
of hydration. The height and weight of each subject was recorded and entered into the
BoMed ® NCCOM3 ® Cardiovascular Monitor (BoMed Medical Manufacturing, Ltd.,
Irvine, CA 92718). Each subject was fitted with BoMed #04-030 Pre-gelled disposable
electrodes. Two electrode pairs were placed on the neck with the uppermost member of
each pair(current electrodes) even with the angle of the jaw. Two lower pairs of
electrodes were placed on each side of the thorax with the uppermost electrode of each
pair at the level of the ziphoid process.
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Theverticaldistance,L, betweenthe two innermost (sensing) electrodes was
recorded for use in calculating stroke volume by Kubicek's method. Circumferential band
electrodes were not used in this study.
Ultrasound measurements were made on a Biosound Genesis II®(Biosound
Corporation, Indianapolis, IN 46250) echocardiograph system with a 2.0MHz CW
Doppler probe. Two dimensional images of the Aortic Outflow tract (Ao2D) were also
made with the Genesis II operating in the B-Mode.
Data for each subject were recorded on a TEAC (Teac, America Inc., Montebello,
CA 90640) MR-30 Cassette Data Recorder running at 9.52 cm/s. This speed provided
bandwidths of 100Hz - 18.gkHz in the direct-record mode used for the CW Doppler
signals and DC - 2.5kI-Iz in the FM mode.
Output signals from the NCCOM3 include the following signals:
AZ(1V = 0. If'l), dz/dt(lV = 1D./s), ECG(lv = lmV) and Digital Signals(RS-232
9600 Baud, 11 bit format, 1 Start bit, 7 data bits, even parity, 2 stop bits)
In the slow mode, the NCCOM3 averages 16 beats and outputs the following
derived parameters via the serial I/O port: Cardiac Output (L/m), Stroke Volume(ml),
End Diastolic Volume(ml), Peak Flow(ml/s), Ejection Fraction(%), Heart Rate(beats/m),
Thoracic Fluid Index (Zo), Index of Contractility(sec "1), Ejection Ratio(%), Systolic Time
Ratio(%), Acceleration Index(sec'2), Time (every minute)
In the fast mode, the NCCOM3 provides the following data on a beat by beat
basis: Cardiac Output(L/m), Stroke Volume(ml), End Diastolic Volume(ml), Peak
Flow(ml/s), Ejection Fraction(%), Heart Rate(beats/m), Time(every minute)
Data stored on magnetic tape included the following: CW Doppler audio from the
echocardiograph(direct record mode); ECG from the NCCOM3; AZ from the NCCOM3;
dz/dt from the NCCOM3; Event Marker; Serial (RS-232, 2400 Baud) Baud rate shitter
data from the NCCOM3 and Voice
Video and audio output from the Genesis II echocardiograph were also recorded
on a Panasonic 6300 Video Cassette Recorder for post processing of Ao2D and CW
Doppler signals. Serial data from the NCCOM3 were at 9600 Baud which required a
bandwidth beyond the capability of the TEAC MR-30 recorder. Baud rates were shiiled
to 2400 Baud through the use of a Black Box ® (Black Box Corporation, P.O. Box
12800, Pittsburgh, PA 15241-0800) CMA02A interface adapter. The CMA02A buffers
the incoming 9600 Baud data and outputs it at 2400 Baud. The 2400 Baud signals are
then recorded on the TEAC Recorder on an FM channel.
After the subject was fully instrumented, appropriate data entered into the
NCCOM3 and recorded on tape, the Ao2D measurements were taken with the Genesis II
Echocardiograph while the subject was placed left-side-down. After the aortic dimensions
29-7
were measured, the subject was required to lie in the supine position on a Stryker Circle ®
Bed (Stryker Corporation, Kalamazoo, MI 49001).
During the next four minutes of testing, the following protocol was followed for
each subject at each ofthree (supine, 10 ° head down and 30o head up) positions.
Minute 1
NCCOM3 set to the Slow Mode (averages every 16 "good" beats) and CW
Doppler measurements made at the Suprastemal Notch.
Minutes 2 and 3
The NCCOM3 was switched to the Fast Mode (beat x beat analysis of stroke
volume and cardiac output) and CW Doppler signals taken.
Subject was required to breath normally for 15 seconds then hold breath for 5
seconds. This process was repeated 6 times over the next two minutes.
Minute 4
One minute period of data acquisition during which the NCCOM3 was placed in
the Slow Mode and ultrasound measurements taken.
Sequencing was done through the audio channel on the VCR and TEAC tapes,
event marks on the TEAC tape and Image Reversal (Flash) on the Genesis II
Echocardiograph.
ECG, AZ and event waveforms were transcribed to PC floppy disks by playing
back the FM analog tapes through a DATAQ (DATAK Instruments, Akron, Ohio) analog
to digital converter using DATAQ's CODAS Signal analysis software. Each data channel
was digitized at 100 samples per second. The dz/dt data were not digitized because dz/dt
could be obtained by differentiating the AZ channel using the CODAS software. Peak
values of dz/dt and VET could then be determined manually for the SV K and SV S and
automatically, via the NCCOM3 unit for SVBM
Figure 3 shows representative tracings of the transcribed data used for analysis. This
protocol permitted collection of 4 successive heart beats and the associated impedance
signals. For individuals with extremely low heart beats, with R-R intervals exceeding
1.25s, only 2 or 3 successive beats were acquired.
RESULTS
After data collection, the analog and serial data were transferred to PC-compatible
floppy disks. Analog data were separated by event (supine, 10o head down, 300 head
up). ECG, AZ and event mark were transcribed initially. Then using the CALC feature of
the CODAS Signal Processing Software, the AZ data were differentiated to produce a
dz/dt channel. Peak dz/dt(referred below as IMPSIG) and VET measured during each
breath-hold sequence were then manually determined and transferred to a Quattro ®
_orland International, Inc., Scotts Valley, CA 95067-0001) spread sheet for processing.
Stroke volumes using Kubicek's and Sramek's formulae were then calculated using the
following equations:
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SVK - (IMPSIG/10*VET* 135*L2)/TFI 2
SV S = (IMPSIG/10*VET*VEPT)/TFI
Since TFI data were not available on a beat-to-beat basis, the TFI values were determined
just before and just after the 2 minute test series. The two readings, when different, were
averaged.
Stroke volumes from the BoMed NCCOM3 were taken directly from the serial
output data for the same time interval as the impedance data and entered into the spread
sheet as SVBM. Doppler echocardiographic data were obtained from the Genesis II
Echocardiograph. These data were obtained for the same beats as the impedance data.
In some cases, all 4 beats were not obtainable because of frame misalignment on the VCR.
In these cases data were obtained for as many beats as possible.
 :] JJJJJJ !
Figure 3.-Digitized data showing event marker that denotes start and finish of 5 second
breath-hold sequence. Six &these sequences are performed during a 2 minute test
interval at each position. The breath-hold sequence(arrows) eliminates the respiration
artifact in the impedance signals.
The data were reduced by averaging the beats taken during the 5 second breath-
hold sequences. In this way, each data point represents the average stroke volume, for
Doppler and Impedance methods, for each 5 second period. To normalize the data for
size differences between subjects, each Stroke Volume value was divided by Body Surface
Area (BSA) to obtain Stroke Index.
An Analysis of Variance (A_NOVA) was performed to test significant effects for
replications, sex, and event(tilt). The results are Shown in Table I with values <0.05
considered to be statistically significant.
These results indicated there were no significant differences in replications so that
the 6 data points for each condition could be combined. Also ofnote is the fact that there
was a significant interaction for the sex-by-tilt grouping. Analysis of simple effects
showed that all impedance methods were highly significant for sex(P___0.001). Doppler
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was not significant for sex except for the 30 ° head-down tilt case which was highly
significant (P<0.001 )
Table I.-ANOVA results to test the significant effects for sex, replications(REPS)
and tilt.
SEX REPS TILT SEXby SEXby TILT by 3 way
REPS TILT REPS
SIBM .0001 .9922 .0001 .8044 .0046 .999 .999
SI K .0001 .9802 .0001 .98 .0922 .9917 .984
SIS .0001 .9878 .0001 .9813 .0026 .9878 .910
SI D .0001 .6037 .0001 .9181 .0132 .9919 .946
To observe the effects of tilt, the percent change in stroke index for the three tilt
events, using combined data, were plotted. These results are shown in Figure 4.
Statistical analysis (P<0.05)showed that differences between events 1 and 2 were not
significant but that event 3 was different from both groups 1 and 2. There were no
significant differences between groups, i.e., all 4 methods produced equivalent results.
Scatter plots of stroke indices of all three impedance methods are shown in Figure 5.
To test the validity of the NCCOM3 algorithm to detect and differentiate the AZ
signal, a scatter plot of SI S by SIBM was done and shown in Figure 6.
PERCENT CHANGE IN STROKE INDEX
FROM SUPINE POSITION
10
0
-_0
-2O
-30
KUBICEK
8OUEO
SRAMEK
DOPPLER
. i , I ,
_ 2 3
£VEN_
Figure 4.-Combined data showing percent change in stroke index as caused by head-up(2)
and head-down(3) tilt from the supine(I) position. Vertical bars are 95% confidence
limits.
DISCUSSION
In looking at the percent change (Figure 4) data there was a significant shift in the
cardiac output from the 10 ° head-down position to the 30 ° head-up position. The
magnitude of change from the head-down to head-up positions were roughly the same for
all 4 methods. The Doppler and Sramek's method showed parallel effects. The BoMed
method showed a slightly reduced sensitivity (lower slope) and the Kubicek method
showed a slightly increased sensitivity(steeper slope) to positional changes. Using
Duncan's Multiple Range Test to compare means there were no significant differences
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Figure 5.-Comparison of stroke indices of Kubicek x Doppler, BoMed NCCOM3 x
Doppler and Sramek x Doppler. The solid line represents the linear regression line for the
data. The dotted line represents the line of identity along which the data would lie if the
variables were equivalent. R 2 values for the three groups are 0.02, 0.05 and 0.01
respectively.
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among any of the 4 methods within any treatment group (degree of tilt) however there
were significant interactions between degree of tilt and sex.
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Figure &-Scatter plot of stroke index calculated by Sramek's equation and the BoMed
NCCOM3 cardiovascular monitor. The data should fall on the line of identity with an R 2
value of 1.0. The data exhibit a bi-modal distribution with a low R 2 value of 0.08. The
reason for this distribution is not clear.
Looking at the scatter plots of the three impedance methods and Doppler, there
appeared to be no correlation among any of the events. Correlation coefficients were less
than 0.1 in all cases. This indicates that either impedance (all three methods) or Doppler
or both are not measuring stroke volume. Since the Doppler echocardiographic analysis
of percent change studies produced the expected results, one can suspect that the
echocardiograph is measuring a real quantity, namely stroke volume. On the other hand,
one cannot assume this of the bioimpedance signals because of the changes in TFI that
occur with postural changes.
One is then led to consider these two apparent contradictory results, namely
acceptable results when percent change from supine is considered and random results
when comparing Doppler to bioimpedance. The assumption must be that something else
is affecting the impedance signals. A likely culprit is the TFI signal which also varies with
positional changes. A look at equations (2) and (5) show that a change in TFI will
produce changes in stroke volume in the direction observed. It should also be noted that
the change in SV K will produce a steeper slope because of the squared term that appears
in the denominator.
In order to determine to what extent the TFI changes would have on stroke
volume or stroke index, the data were recalculated by keeping all variables constant
except for TFI. The constant was taken as the mean dz/dt, mean VET, mean L and mean
VEPT over all trials. For the Kubicek equation, p was taken as 13 5fl-cm. The results of
this investigation were plotted against the percent change data and are shown in Figure 7.
This analysis demonstrates that a major portion of the change that is seen in the
three test groups is due to changes in TFI and not due to measured changes in dz/dt and
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VET. Statisticalanalysesdemonstrated highly significant diff'erences in the TFI data by
sex, by tilt and by sex*tilt (P<0.001).
A second set of statistical analyses keeping TFI constant showed the following:
For the Kubicek Data, sex was not significant but tilt was (P_<0.05) when moving
from the head-down(2nd)to the head-up(3rd) position.
For the Sramek data, sex and tilt were both signific .ant (P___0.05) when moving
from the 2nd to 3rd position.
Comparison of the stroke index as calculated from Sramek's formula and the
digital output of the NCCOM3 showed no overall correlation but some of the data did
appear to fall on the line of identity. The rest of the data accumulated around a second
slope giving the data a bi modal appearance. At this time it is not known why this bi
modal distribution occurred nor is it known which data belong to what group.
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Figure 7.-Percent change in stroke index from the supine position with TFI results added.
The TFI data represent changes in stroke index that can be attributed to TFI only.
CONCLUSIONS
This study was initiated in order to validate the bioimpedance measurements of
stroke volume and cardiac output. Doppler echo velocimetry has been used in the
cardiovascular laboratory and on several missions aboard the space Shuttle. The problem
with the technique is the cost of the equipment and the skill level necessary to use it.
Bioimpedance, on the other hand, has been purported to be accurate yet inexpensive and
does not require the skill level of echocardiography.
This study, however, does not support the use of bioimpedance measurements in
conjunction with the space program. Analysis of the data collected during this study show
no correlation between stroke volume measured by echocardiography and that measured
by bioimpedance. Furthermore, it appeared that the changes that were detected were due
to shifts in thoracic fluid and consequential changes in Thoracic Fluid Index (Basal
Impedance, Zo).
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Comparisons of the BoMed NCCOM3 monitor with manually derived values,
using the same equations, showed no overall correlation though a small group of data
points did appear to correlate well. This result indicates that the algorithm that is intemal
to the NCCOM3 does not agree well with manually-derived results and that neither of the
methods is particularly quantitative.
Reasons for the apparent lack of correlation are unknown at this time. If we
assume that the manual calculations of Kubicek's and Sramek's equations were faulty, then
the BoMed results should have been acceptable, but they were not. If we assume that the
BoMed internal algorithm was faulty, then Kubicek's and Sramek's methods should have
worked out well, but they did not. Several of the subjects dz/dt waveforms were difficult
to interpret because of double dz/dt peaks or because of indistinct VETs. These data were
in the minority and would not affect the overall results.
It is possible that the BoMed NCCOM3 used was producing noisy AZ signals
which would lead to noisy, randomized results. It is also possible that the BoMed
electrode system used is not at all suitable for this type of study. Until these questions are
answered, however, use of this system to study stroke volume and cardiac output is not
recommended. Relative changes in stroke volume or cardiac output and the measurement
of TFI may find some use in the program but further research needs to be conducted..
It is recommended that this series of experiments be repeated with the following
changes:
Use a different bioimpedance monitor, for example use the Minnesota Impedance
Cardiograph or build one.
Since the Ventricular Ejection Time is sometimes difficult to determine using the dz/dt
waveform, it would be better to identify systole acoustically with a phonocardiograph
microphone.
Use circumferential electrodes since it is not clear whether the BoMed electrodes provide
the uniform current densities that this technique requires.
Continue to use Kubicek's and Sramek's formulae since variables for Sramek's formula are
easier to obtain and do not require calculations based on the subject's hematocrit.
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Note:
W.G. Kubicek has compiled and published A Bibliography of Publications Related to
Impedance Cardiography which contains 546 listings on the subject. This compendium of
civilian and space flight, can be obtained by writing to:
W.G. Kubicek, Ph.D., Professor Emeritus
University of Minnesota Medical School
4180 Edmund Blvd.
Minneapolis, MN 55406
Also note that numerous publications by Sramek, the developer of the competing BoMext
Impedance Cardiograph, do not appear to be listed in this compendium. Sramek, tends to
publish in "throw-away" magazines (Medical Electronics, Critical Care Medicine and his
own publications) and it is possible that Dialog Information Services, Inc. (the source of
Kubicek's bibliography) does not index these magazines.
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